ClinicalTrials.gov · 2026
SUPREME-01 (NCT07140939): Phase 3 CBL-514 for abdominal subcutaneous fat
ClinicalTrials.gov (2026). SUPREME-01 (NCT07140939): Phase 3 CBL-514 for abdominal subcutaneous fat. Clinical trial registry.
Clinical trial registry
Source: https://clinicaltrials.gov/study/NCT07140939
Last reviewed . By the PeptIQ team.
Peptides linked in PeptIQ Wiki
This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.